Who invested in EpiBiologics?
EpiBiologics's investors include Polaris Partners, Vivo Capital, Samsara BioCapital, Digitalis Ventures and Mission BioCapital.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$107Mraised across 1 round since 2026, from 1 source
Source recorded
From the SEC filings it signed: 2 on the team.
On the board, as filediAlexandra CantleyJames WellsJason ColomaSamuel BjorkSeiji Miyahara
EpiBiologics's investors include Polaris Partners, Vivo Capital, Samsara BioCapital, Digitalis Ventures and Mission BioCapital.
EpiBiologics has raised $107M across 1 round since 2026.
EpiBiologics's most recent round was a Series B of $107M in Jan 2026.
Its most recent round, $107M in Jan 2026, is also its largest on record.
EpiBiologics's first round on record, in Jan 2026, was backed by Polaris Partners, Vivo Capital and Samsara BioCapital and 2 others.
EpiBiologics's latest named round is a Series B, in Jan 2026.
EpiBiologics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.